Chemoinformaics analysis of Selina-1,3,7(11)-trien-8-one
| Molecular Weight | 216.324 | nRot | 0 |
| Heavy Atom Molecular Weight | 196.164 | nRig | 13 |
| Exact Molecular Weight | 216.151 | nRing | 2 |
| Solubility: LogS | -3.626 | nHRing | 0 |
| Solubility: LogP | 3.409 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
| Atoms Count | 36 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 39.1879 |
| nHD | 0 | BPOL | 20.9321 |
| QED | 0.562 |
| Synth | 4.436 |
| Natural Product Likeliness | 2.883 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.805 |
| Pgp-sub | 0.033 |
| HIA | 0.006 |
| CACO-2 | -4.611 |
| MDCK | 0.000034 |
| BBB | 0.133 |
| PPB | 0.846121 |
| VDSS | 0.877 |
| FU | 0.218729 |
| CYP1A2-inh | 0.139 |
| CYP1A2-sub | 0.468 |
| CYP2c19-inh | 0.312 |
| CYP2c19-sub | 0.871 |
| CYP2c9-inh | 0.151 |
| CYP2c9-sub | 0.072 |
| CYP2d6-inh | 0.458 |
| CYP2d6-sub | 0.165 |
| CYP3a4-inh | 0.44 |
| CYP3a4-sub | 0.656 |
| CL | 11.289 |
| T12 | 0.398 |
| hERG | 0.028 |
| Ames | 0.009 |
| ROA | 0.905 |
| SkinSen | 0.928 |
| Carcinogencity | 0.862 |
| EI | 0.174 |
| Respiratory | 0.978 |
| NR-Aromatase | 0.012 |
| Antiviral | Yes |
| Prediction | 0.772673 |